Spotlight Correspondence
Leukemia (2003) 17, 1186–1187. doi:10.1038/sj.leu.2402938
Imatinib mesylate (GleevecTM) reduces phlebotomy requirements in polycythemia vera
R T Silver1
1New York Presbyterian-Weill Cornell Medical Center, New York, NY 10021, USA
Correspondence: Dr RT Silver, New York Presbyterian-Weill Cornell Medical Center, 525 East 68th Street, Box 581, New York, NY 10021, USA. Fax: +1 212 746 8246
Received 29 January 2003; Accepted 11 February 2003.
